Pulmonary Function Testing (PFT) is a complete assessment of respiratory system comprising patient history, chest x-ray examinations, physical examinations, arterial blood gas analysis, and tests of pulmonary function. Its primary purpose is to identify the severity of pulmonary impairment & respiratory issues. It is used to measure the rate of flow, gas exchange & lung volume capacity. The testing systems help to diagnose lung disorders along with treatment or therapeutics for lung disorders. It is normally performed by a respiratory therapist, pulmonologist, physiotherapist, and/or general practitioner.
Some of the risk associated with PFT systems include dizziness during the tests, coughing, feeling short of breath and asthma attack brought on by deep inhalation.
According to study, “Pulmonary Function Testing Systems Market Research Report by Type (Complete PFT Systems, Portable PFT Systems, and Others), Test Type (Spirometry, Lung Volume, Gas Exchange Testing, and Others), Component (Software, Hardware, Service, and Others), Application (Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, and Others), End-user (Hospital/Clinical Laboratories, Diagnostics Laboratories, and Others), and Region-Global Forecast to 2023” the key companies operating in the pulmonary function testing systems market are Medical Equipment Europe GmbH, COSMED srl, Vyaire Medical, Inc., MGC, Diagnostic Corporation, Schiller ECO MEDICS AG, Medical Electronic Construction, CHEST M.I., Inc., NDD Medical Technologies.
Based on type, PFT system market is segmented into portable PFT systems, complete PFT systems, and others. Based on test type, market is segmented into lung volume test, spirometry test, gas exchange testing, maximal voluntary ventilation, high altitude simulation testing, oxygen titration test and others. The lung volume tests are tidal volume (VT), expiratory reserve volume (ERV), inspiratory reserve volume (IRV), and residual volume (RV). Based on techniques, market is segmented into nitrogen washout, helium dilution and plethysmography. Based on applications, market is segmented into asthma, restrictive lung disease, chronic shortness of breath, chronic obstructive pulmonary disease, preoperative testing, early morning wheezing, impairment or disability and others. In addition, based on end-user, market is segmented into diagnostics laboratories, hospital/clinical laboratories, and others.
The PFT system market is driven by growth in an elderly population, followed by rise in prevalence of lung cancer and increase in prevalence of respiratory diseases. However, rise in cost of pulmonary devices and stringent regulatory policies may impact the market. Moreover, environmental effects and change in life style are major opportunities for market.
Based on geography, The America region dominates the PFT system market followed by European region, owing to growth in technological advancements in diagnostics, increase in prevalence of lung diseases such as asthma, COPD, rise in prevalence of respiratory diseases & other pulmonary disorders and surge in demand for lung function tests in the region. The Asian-Pacific region is expected to be the fastest-growing market due to growth in demand for pulmonary function testing devices in private hospitals or clinics over the forecast period. Moreover, the Middle East & Africa region is estimated to witness steady growth as a result of rise in healthcare infrastructure and increase in demand for products during the forecast period. It is predictable that the market will be reached at speedy pace as a result of presence of a massive patient population during the forecast period.
For more information, click on the link below:
Ankur Gupta, Head Marketing & Communications